Stock Market Impact: Shares of Shattuck Labs Inc (NASDAQ:STTK) fell 3.9% in after‑hours trading following the announcement of a public offering of common stock or pre‑funded warrants.
Listed Companies and Sectors: The clinical‑stage biotechnology company, developing DR3‑blocking antibodies (lead program SL‑325), disclosed the offering, which could lead to dilution for existing shareholders.
Investment Flows: The offering, with underwriters granted a 30‑day option to purchase up to an additional 15% of shares at the offering price, may attract new capital from institutional investors.
Interest Rates, Inflation, Liquidity: No related monetary policy measures were mentioned.
Fiscal or Monetary Policy: No fiscal or monetary policy actions were referenced.
